C12N 2760/12041
Use of virus, viral particle or viral elements as a vector
C12N2760/12041 (Use of virus, viral particle or viral elements as a vector) appears on 4 US grants and 8 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 8
- Assignees
- 7
- Inventors
- 22
- Latest grant
- 18 Jun 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 2 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 1 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 2 |
| 2023 | 0 | 1 |
| 2024 | 1 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2760/12043Viral genome or elements thereof as genetic vectorIndexing code4
- C12N 2760/12042Virus or viral particle as vehicleIndexing code0
- C12N 2760/12044Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code0
- C12N 2760/12045Special targeting system for viral vectorsIndexing code0
Recent patents
- EBIV nucleic acid composition and application thereof18 Jun 2024US 12,013,390 B2Wuhan Institute of Virology, Chinese Academy of Sciences
- Methods to produce bunyavirus replicon particles23 May 2017US 9,657,278 B2Stichting Dienst Landbouwkundig Onderzoek
- Infectious Schmallenberg virus from cloned CDNAS and uses thereof26 Jan 2016US 9,241,960 B2Boehringer Ingelheim Vetmedica GmbH
- Methods to produce bunyavirus replicon particles18 Aug 2015US 9,109,199 B2Stichting Dienst Landbouwkundig Onderzoek
- Crimean-congo hemorrhagic fever virus replicon particles and use thereof15 Jan 2026US 2026/0014243 A1The U.S.A., as represented by the Secretary, Department of Health and Human Services
- Negative-strand rna viral vector and plant genome editing method without transformation4 Jul 2024US 2024/0218385 A1Zhejiang University
- Ebiv nucleic acid composition and application thereof16 Nov 2023US 2023/0366877 A1Wuhan Institute of Virology, Chinese Academy of Sciences
- Rose rosette virus infectious clones and uses thereof16 Jun 2022US 2022/0186244 A1
- Crimean-congo hemorrhagic fever virus replicon particles and use thereof27 Jan 2022US 2022/0023410 A1The United States of America, as represented by the Secretary, Department of Health and Human Servic
Most cited
By later US patents